Kidney Function Slipping? Where Stem Cell Therapy Fits. Stem cell therapy for kidney disease: eGFR and stages, proven kidney protection, where MSC therapy fits, suitability, risks and questions to ask.
Stem cell therapy for kidney disease is supportive and still early. It does not replace blood pressure, sugar control or kidney medicines, and it is usually only discussed in early to moderate chronic kidney disease.
Many people first hear about their kidneys from a blood test. The doctor mentions that the eGFR, a number estimating how well the kidneys filter, has dropped, or that there is protein in the urine. Often there are no symptoms at all.
Chronic kidney disease (CKD) usually develops slowly over years. The most common causes are diabetes and high blood pressure, followed by long-term inflammation, kidney stones, some medicines and inherited conditions. When people see the number keep falling, they often search for stem cell therapy for kidney disease.
| Stage | eGFR | What It Usually Means | |---|---|---| | 1-2 | 60 or above, with kidney damage signs | Mild, often no symptoms | | 3a-3b | 30-59 | Moderate loss, regular checks needed | | 4 | 15-29 | Severe loss, planning for the future | | 5 | Below 15 | Kidney failure, dialysis or transplant discussed |
Most of the hope around cell-based care sits in the earlier stages, where there is still working kidney tissue to protect.
The strongest protection still comes from everyday medical care:
These steps slow decline for most people and should never be dropped. The link between sugar and kidney damage is explained in diabetes complications care.
MSC therapy is being explored as a supportive option. MSCs release signals that could:
Early reports suggest some people may hold their kidney numbers steadier, but evidence is still limited and results vary. It does not regrow lost kidneys or replace dialysis. Exosome support is a cell-free option some people discuss for the same goals.
More commonly considered:
Usually not suitable:
A physician reviews recent eGFR, urine protein, blood pressure records and medicines before travel. In clinic, blood and urine tests are repeated, and the team explains whether MSC therapy, exosome support, IV nutrient support or simply better baseline care fits best. Drips run slowly with fluid balance in mind, and follow-up blood tests at home are planned with the person's own kidney doctor.
Stay length depends on the plan, explained in how long to stay in Bangkok.
These signs need prompt local medical care, not a planned overseas trip.
It is not shown to reverse CKD. It is explored to help protect remaining function.
No. Dialysis and transplant remain the options for kidney failure.
It is usually well tolerated, but fluid, medicines and kidney numbers are checked first.
No. Kidney medicines and blood pressure control remain essential.
Some people stay stable, a few improve slightly, and others continue to decline. It varies.
When kidney function starts slipping, the strongest protection still comes from blood pressure and sugar control, kidney-protecting medicines and diet changes, and none of these should be dropped. Stem cell therapy for kidney disease, such as MSC therapy or exosome support, is an early supportive option usually discussed for stage 2 to 3 CKD to calm inflammation and scarring signals, not to reverse damage or replace dialysis, so a physician review of recent results comes first. More context is in stem cell therapy in Bangkok.
1. Chronic kidney disease - MedlinePlus 2. Chronic kidney disease - NIDDK 3. Mesenchymal stem cells chronic kidney disease - Google Scholar